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Acute laryngeal dyspnea as first presentation of granulomatosis 
with polyangiitis
Ostra duszność krtaniowa jako pierwszy objaw ziarniniakowatości z zapaleniem naczyń
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Abstract
Granulomatosis with polyangiitis (GPA) is a multi-organ disease which mostly affects lungs, kidney, and head and neck region. We 
report a rare case of acute laryngeal dyspnea and rapidly progressive pulmonary changes as first manifestations of disease. A 53 
year-old woman presented with symptoms of two-week dyspnea, which aggravated rapidly in the preceding hours. Laryngologi-
cal examination revealed subglottic infiltrations and vocal fold oedema which required urgent tracheotomy. During few days she 
developed gingival ulcerations and pulmonary infiltration with negative serum c-ANCA titers. The histopathological examination 
of subglottic and gingival biopsies and the clinical picture established the diagnosis of GPA. She was treated with prednisone 
and cyclophosphamide with recovery; however, during over 3 years of follow-up, pulmonary symptoms relapsed and subglottic 
stenosis persisted. The difficulties in diagnosis and treatment in this unusual presentation of GPA are outlined with conclusion 
that in patients with subglottic infiltration, which develops rapidly, even when this is a sole presentation of the disease, and when 
c-ANCA are negative, GPA should always be considered.
Key words: granulomatosis with polyangiitis, subglottic stenosis, pulmonary symptoms
Pneumonol Alergol Pol 2015; 83: 216–219
Streszczenie
Ziarniniakowatość z zapaleniem naczyń (GPA) jest wielonarządową chorobą, która najczęściej dotyczy płuc, nerek oraz regionu 
głowy i szyi. Autorzy przedstawiają rzadki przypadek ostrej duszności krtaniowej jako pierwszego objawu choroby. Kobieta lat 
53 zgłosiła się z powodu trwającej od 2 tygodni duszności, która nasiliła się znacznie na kilka godzin przed przyjęciem. W bada-
niu laryngologicznym stwierdzono naciek okolicy podgłośniowej i obrzęk fałdów głosowych, wymagające pilnej tracheotomii. 
W kolejnych dniach u chorej wystąpiły owrzodzenia dziąseł i nacieki w płucach, przy braku obecności przeciwciał c-ANCA. Na 
podstawie badania histopatologicznego wycinków z okolicy podgłośniowej i dziąseł oraz obrazu klinicznego ustalono rozpoznanie 
GPA. W leczeniu zastosowano prednison z cyklofosfamidem i uzyskano poprawę, w okresie ponad 3-letniej obserwacji wystąpił 
jednak nawrót objawów płucnych, utrzymywało się zwężenie podgłośniowe. W pracy zwrócono uwagę na trudności w postę-
powaniu diagnostyczno-terapeutycznym podkreślając rolę podgłośniowego obrzęku krtani jako jedynej początkowo manifestacji 
GPA, nawet przy braku obecności przeciwciał c-ANCA.
Słowa kluczowe: ziarniniakowatość z zapaleniem naczyń, zwężenie podgłośniowe, objawy płucne
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Introduction
Granulomatosis with polyangiitis (GPA, 
formerly Wegener’s granulomatosis), an auto-
immune disorder characterized by necrotizing 
granulomatous inflammation of small-to-medium 
vessels, is a part of ANCA (antineutrophil cyto-
plasmic antibodies)-associated vasculities (AAV), 
which includes also eosinophilic granulomatosis 
with polyangiitis (eGPA, formerly Churg-Strauss 
syndrome) and microscopic polyangitis (MPA).
GPA is a multi-organ disease which mostly 
affects lungs, kidneys, and head and neck region. 
The nose and paranasal sinuses are the common-
est sites of head and neck involvement at the 
initial presentation of GPA (in the form of nasal 
septal perforation, chronic rhinosinusitis, epi-
staxis, saddle nose deformity). The other locations 
like ear, eye and larynx are far less common [1]. 
We report a rare case of acute laryngeal dyspnea 
and rapidly progressive pulmonary changes as 
first manifestations of disease. The institutional 
review board of the Medical University of Lodz 
has approved the publication of this case report.
Case report
Female 53 year-old smoker (20 pack-years) 
was admitted to the Otolaryngology Department 
due to two-week dyspnea, which aggravated 
rapidly in the preceding hours. Laryngologi-
cal examination revealed subglottic infiltration 
and vocal fold oedema (Fig. 1). Initial laborato-
ry tests showed high white blood cells (WBC) 
(25.0 G/L, 74.5% of neutrophils) and C-reactive 
protein (74.9 mg/l) levels. Urgent tracheotomy 
and laryngoscopy with biopsy of subglottic le-
sions were performed. On the fifth day of the 
postoperative period, patient’s body temperature 
rose, and after next 2 days she developed erosive 
and haemorrhagic lesions on gingiva, from which 
biopsy was taken. First chest X-ray was normal, 
but the second one, 5 days later, demonstrated up-
per right lobe cavitating infiltration (12 × 32 mm). 
Both sugblottic and gingival biopsy revealed high 
intensity chronic inflammation and mild epithe-
lial dysplasia with ulceration and granulation, 
highly suggestive of GPA. Serum c-ANCA was 
negative. Patient was transferred to Department 
of Pneumonology and Allergy, where chest com-
puted tomography (CT) revealed thick-walled 
cavities of different size in the lungs, with few 
subpleural nodules and slightly enlarged subca-
rinal lymph nodes (13.5 mm in diameter) (Fig. 2). 
Laboratory results showed persistent increase 
Figure 1. Bronchoscopic image 5 days after patient’s admission indi-
cating vocal fold oedema and subglottic infiltration 
Rycina 1. Obraz bronchoskopowy w 5-tym dniu po przyjęciu chorej do 
szpitala — obrzęk fałdów głosowych i naciek okolicy podgłośniowej 
krtani
Figure 2. Chest computed tomography — two infiltrations with cavi-
tations in the upper left lobe (indicated by arrows)
Rycina 2. Badanie tomografii komputerowej klatki piersiowej — dwa 
nacieki z rozpadem w górnym płacie lewego płuca (strzałki)
of inflammatory markers: C-reactive protein 
(30 mg/l) and WBC (19.0 G/L). At the beginning 
antibiotics were introduced, but after biopsy re-
sults had become available, prednisone (1 mg/kg) 
and cyclophosphamide (CYC, 2 mg/kg) were start-
ed. The patient slowly recovered, but one year 
later, when prednisone was tempered to 10 mg 
per day and CYC was replaced with azathio-
prine (AZA), symptoms relapsed. She presented 
progressive dyspnea with new infiltrations on 
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ing their pathogenic role in the development of the 
disorder. Proteinase 3-ANCA (PR 3-ANCA,c-AN-
CA) and myeloperoxidase-ANCA (MPO-ANCA, 
p-ANCA) can activate neutrophils, enhance their 
adhesion to endothelial cells, resulting in release 
of reactive oxygen species and lytic enzymes 
which damage vessel walls. Recently, it was 
found that the number and function of T regula-
tory lymphocytes CD4+CD25+FoxP3+Treg were 
decreased in patients with GPA as compared to 
healthy controls. Moreover, increased proportion 
of Treg lymphocytes was associated with more 
rapid remission [7]. The role of B-lymphocytes 
as anti PR 3-ANCA producing IgG is more clear. 
These cells were found in close proximity to PR-3 
positive cells in the sites of granulomatous inflam-
mation. As a trigger for GPA, environmental fac-
tors as well as infections and/or nasal carriage of 
Staphylococcus aureus should be considered [8]. 
It is well documented that about 25−40% of patients, 
mainly those with limited GPA, have undetectable 
ANCA [4, 9] and this was at the beginning in our case.
In presented case, after introducing CYC 
and corticosteroids, regression of the pulmonary 
changes was observed. Conventional immunosup-
pressive therapy is powerful enough to produce 
a remission in 90% of patients, but relapses 
of the disease are common [6]. There are some data 
suggesting that trimethoprim-sulfamethoxazole 
may be beneficial in reducing trigger factors con-
tributing to exacerbation of GPA, mainly in patients 
with localized disease [10]. Recently, in severe 
refractory GPA, rituximab — monoclonal antibody 
against CD20 (B lymphocytes) has become the first-
line agent for remission induction and to prevent 
relapses in chronically relapsing patients [11].
An important observation from the presented 
case is, that subglottic stenosis persists or even 
progresses, despite otherwise effective immuno-
suppressive treatment. It has been reported that 
only about 20−26% of patients improve after 
systemic treatment, while the remaining patients 
may require local surgical interventions [5]. The 
therapeutic options for subglottic stenosis consist 
of endoscopic dilatation, endoscopic laser exci-
sion or surgical resection of involved segment 
followed by reconstruction [5, 12]. Using endo-
scopic technique to remove a stenotic part with 
subsequent soaking of these areas with mitomy-
cin-C (due to its antifibroblastic activity), Arebro 
et al. [13] reported an overall success rate of 85%. 
Langford et al. [3] proposed new technique based 
on intralesional long-acting corticosteroid injec-
tion which seems more effective local therapy in 
subglottic stenosis [4, 14, 15].
Figure 3. Bronchoscopic image showing protracted subglottic 
stenosis 
Rycina 3. Obraz bronchoskopowy — przetrwałe zwężenie podgło-
śniowe
chest X-ray. The level of c-ANCA at that time 
was slightly increased (titer 1:32). Treatment 
with AZA and prednisone was intensified and 
resulted in good clinical response. At present 
she is continuing treatment (AZA 150 mg/day + 
prednisone 10 mg/day). During over 3 years of 
follow-up she had several bronchofiberoscopic 
examinations, which have shown the gradual 
regression of subglottic infiltration, with residual 
stenosis allowing only the passage of the broncho-
scope to trachea (Fig. 3). Patient did not consent 
to any dilatation procedures; however, she has 
removed tracheostomy tube few months ago and 
breathes without it.
Discussion
Upper respiratory tract involvement has been 
reported in 75−93%, and pulmonary involvement 
in 60−85% of patients with GPA [2]. The main 
finding on chest CT are bilateral nodules and 
cavitating infiltrations. Vasculitis-related severe 
diffuse alveolar haemorrhage may also occur. 
Subglottic stenosis may develop in 7–23% of 
cases, and is very rare as a presenting feature, 
found only in 1−6% [3−5]. Such presentation 
with life-threatening subglottic stenosis is more 
common in younger patients than in patients 
with multiorgan GPA [6]. In the reported case, 
fulminant clinical course requiring tracheotomy 
was followed by the rapid development of lung 
changes.
Although the exact etiology of GPA still re-
mains unclear, ANCA, especially c-ANCA (cyto-
plasmic immunofluorescence pattern) are highly 
specific and sensitive to this disease, thus suggest-
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In conclusion, in patients with subglottic 
stenosis, which develops slowly or rapidly, even 
when this is a sole presentation of the disease, and 
when c-ANCA are negative, GPA should always 
be considered.
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